Business
WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT
WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT Canada NewsWire ...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n \n \n \n WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENT\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n Willow Continues its Transition to the Bay Area in\n \n California\n \n with Management Promotions and a New Board Member\n \n \n \n \n \n \n MOUNTAIN VIEW\n \n , Calif.\n \n ,\n \n \n March 28, 2023\n \n \n /CNW/ - Willow Biosciences Inc. (\"\n \n Willow\n \n \" or the \"\n \n Company\n \n \") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and sustainable ingredients, is pleased to announce that the Board of Directors has appointed Dr.\n \n Chris Savile\n \n , Willow's Chief Operations Officer, as President and Chief Executive Officer and Mr.\n \n Trevor Peters\n \n , a Director and Founder of the Company, as Chairman, effective\n \n March 28, 2023\n \n , in connection with Dr. Peter Seufer-Wasserthal's retirement as President and CEO. Dr. Seufer-Wasserthal will continue to be a Director of the Company.\n \n \n \n \n \n \n \n \n \n \n \n Management and Executive Promotions\n \n \n \n \n Dr. Savile, a leader at Willow since the Company's inception in early 2019, has been appointed President and Chief Executive Officer effective\n \n March 28, 2023\n \n . Since joining Willow, Dr. Savile has led the development of the technology platform, building of the operational capabilities, and expansion of the internal portfolio and external partnerships.  Prior to joining Willow, Dr. Savile worked in senior leadership roles at Intrexon Corporation, a biotechnology company, and Codexis, Inc., a protein engineering company. Chris is an experienced business professional and an accomplished chemist, high-throughput assay scientist, and protein engineer with a strong technical background.\n \n \n \"Chris' extensive scientific knowledge and business development experience will be invaluable to Willow in its next phase of growth,\" said\n \n Trevor Peters\n \n , Chairman of the Board. \"Chris has...